GlaxoSmithKline Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was INR 8,096.3 million compared to INR 7,444.3 million a year ago. Revenue was INR 8,283.9 million compared to INR 7,740.3 million a year ago. Net income was INR 12,190.5 million compared to INR 143.3 million a year ago. Basic loss per share from continuing operations was INR 3.23 compared to basic earnings per share from continuing operations of INR 0.22 a year ago. Basic earnings per share was INR 71.96 compared to INR 0.85 a year ago.